Ruth trained as a pharmacist and then spent a decade watching the gap between clinical trial data and real-world outcomes grow wider every year. She left the industry after a whistleblower case she had quietly supported was settled out of court under a non-disclosure agreement. Her reporting cuts through press releases and FDA approval language to ask the questions that should have been asked before the drug reached the shelf.
13 published posts
Medical FraudBy Ruth Anselmi
Biotechnology company Amgen reveals a cybersecurity incident involving stolen company data and possible patient health information, raising new concerns over healthcare data security.
By Ruth Anselmi
U.S. authorities have uncovered a large-scale Medicare fraud scheme allegedly linked to Russian organised crime, involving fake medical billing and stolen patient data.
By Ruth Anselmi
Clinical laboratory giant Labcorp has agreed to pay $14.5 million to resolve allegations that it submitted false Medicare claims for medically unnecessary urine drug testing services.
By Ruth Anselmi
The Justice Department has sued New York state officials and contractor Public Partnerships LLC, alleging a sham bidding process and unauthorized profits in the state's $10 billion Medicaid home-care program.
By Ruth Anselmi
The FDA has issued warning letters to 25 telehealth companies accused of making false and misleading claims about compounded versions of popular weight-loss and diabetes medications.
By Ruth Anselmi
The United States has launched a Section 301 trade investigation into Germany's pharmaceutical pricing policies, escalating tensions over healthcare costs.
By Ruth Anselmi
Ahold Delhaize, owner of Stop & Shop and Giant pharmacies, agreed to a $40 million settlement after allegations that it inflated prescription prices charged to Medicare, Medicaid and TRICARE.
By Ruth Anselmi
Federal authorities arrested Herbert Leon Kimble in the Philippines for allegedly masterminding a $1.2 billion Medicare fraud operation involving unnecessary orthopedic braces.
By Ruth Anselmi
U.S. investors have filed a lawsuit against clinical trials company Icon, alleging financial misreporting, inflated revenue claims, and misleading disclosures linked to pharmaceutical trial operations.
By Ruth Anselmi
Four people tied to a Shelton pain clinic face charges over an alleged scheme in which APRM Solutions submitted 4,009 false Medicaid claims for allergy treatments that were never performed without proper licensing.
By Ruth Anselmi
A federal jury in Boston found Takeda liable for blocking generic competition to its constipation drug Amitiza — the first pay-for-delay antitrust verdict against a pharma company in U.S. class-action history.
By Ruth Anselmi
HHS Inspector General March Bell decertified Hawaii's Medicaid Fraud Control Unit and cut its $3 million annual federal match after finding zero indictments or convictions for Medicaid fraud between 2022 and 2025 — despite $12 million in federal funding over that period.
By Ruth Anselmi
AstraZeneca will pay nearly $34 million to settle allegations that it used illegal kickbacks to influence prescriptions under Texas Medicaid, resolving a healthcare fraud lawsuit without admitting wrongdoing.
